Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sevim Bavbek"'
Autor:
Sevim Bavbek, Esra Ünsay Metan
Publikováno v:
Tuberk Toraks. 69:369-379
The effective treatment of asthma is important in terms of improving the quality of life and decreasing the number of hospital admissions due to acute exacerbations. Parasymphatic activity is increased in patients with asthma. This is one of most imp
Autor:
Hans Jürgen Hoffmann, Andrea Matucci, Anna Kosowska, Aslı Gelincik, Luis Perez de Llano, Oliver Pfaar, Mario Cazzola, Kari Nadeau, Milena Sokolowska, Alessandra Vultaggio, Eva Untersmayr, Oscar Palomares, Jean-Christoph Roger J-P Caubet, Anna Sediva, Isabel Skypala, Rosan Meyer, Davide Firinu, Montserrat Fernandez-Rivas, Sevim Bavbek, Ronald van Ree, Thomas Eiwegger, Domingo Barber Hernández, Alexia Chatzipetrou, Jonathan Corren, Elizabeth Palmer, Musa Khaitov, Mohamed H. Shamji, Vera Mahler, Oliver Price, Vibeke Backer, Magdalena Zemelka-Wiacek, Cezmi A. Akdis, Florin-Dan Popescu, Margitta Worm, Victoria Del Pozo, Alberto Alvarez-Perea, Annick Barbaud, Sylwia Smolinska, Karin Hoffmann-Sommergruber, Job van Boven, Audrey DunnGalvin, Motohiro Ebisawa, Tomas Chivato, Gunter J. Sturm, André Moreira, Mubeccel Akdis, Barbara Rogala, Ludger Klimek, Ioana Agache, María José Torres, Marek Jutel, Matteo Bonini, Radoslaw Gawlik, Jolanta Walusiak-Skorupa, Marina Atanaskovic-Markovic, Montserrat Alvaro, Stefan Vieths, Stefano Del Giacco, Sarita Patil, Alexandra F. Santos, A. Cianferoni, Charlotte G. Mortz, Antonino Romano, Giorgio Walter Canonica, Sergio Bonini, Antti Lauerma, Hideaki Morita, Knut Brockow, Frédéric De Blay
Immune modulation is a key therapeutic tool for allergic diseases and asthma. It can be achieved in an antigen-specific way via allergen immunotherapy (AIT) or in endotype-driven approach using biologicals that target the major pathways of the type 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa345e634ac7fbfbc4292f7e6e6a5d6d
https://doi.org/10.22541/au.162452341.15060228/v1
https://doi.org/10.22541/au.162452341.15060228/v1
Autor:
Sevim Bavbek, Ghada E. Fouda
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Rituximab is a chimeric monoclonal antibody (mAb) against CD20 molecule which is expressed on human B cells. It has been used for the treatment of various lymphoid malignancies, lymphoproliferative diseases, and rheumatologic disorders. Rituximab is
Autor:
Dilşad Mungan, Zeynep Misirligil, Zeynep Gençtürk, Betül Ayşe Sin, Sevim Bavbek, Ömür Aydın, Yavuz Selim Demirel, Zeynep Çelebi Sözener, Gülfem Çelik, Şadan Soyyiğit, Reşat Kendirlinan
Publikováno v:
Allergy and asthma proceedings. 36(6)
Omalizumab has been a valuable option for patients with severe allergic asthma, but there are only case reports regarding effectiveness of omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA).To evaluate the clinical and functio
Autor:
Onur Boyman, Davide Firinu, Apostolos Bossios, Andrea Matucci, Hans-Uwe Simon, C Kaegi, Edward F. Knol, A. Vultaggio, Sevim Bavbek, Oscar Palomares, Carsten B. Schmidt-Weber, Urs C. Steiner, Cezmi A. Akdis, Alexia Chatzipetrou, Thomas Eiwegger, Mübeccel Akdis, Thomas Harr, François Spertini
Publikováno v:
Allergy
Allergy 70, 727-754 (2015)
Allergy, 70(7), 727. Wiley-Blackwell
Allergy: European Journal of Allergy and Clinical Immunology
Allergy 70, 727-754 (2015)
Allergy, 70(7), 727. Wiley-Blackwell
Allergy: European Journal of Allergy and Clinical Immunology
Biologic agents (also termed biologicals or biologics) are therapeutics that are synthesized by living organisms and directed against a specific determinant, for example a cytokine or receptor. In inflammatory and autoimmune diseases, biologicals hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c1340a2635366a6b699feb7a14d284
https://www.zora.uzh.ch/id/eprint/119017/
https://www.zora.uzh.ch/id/eprint/119017/
Publikováno v:
Case Reports in Immunology, Vol 2015 (2015)
Case Reports in Immunology
Case Reports in Immunology
Rituximab is a monoclonal antibody which targets CD20 in B cells that is used for the treatment of CD20 positive oncologic and hematologic malignancies. Rituximab causes hypersensitivity reactions during infusions. The delay of treatment or loss of a
Publikováno v:
International Archives of Allergy and Immunology. 142:64-69
Background: The anti-inflammatory actions of acetylsalicylic acid (ASA)/non-steroidal anti-inflammatory drugs (NSAIDs) are thought to be due to inhibition of COX-2, whereas the side effects such as gastric damage and aspirin-induced asthma are mediat
Autor:
Zeynep Misirligil, Dilssad Mungan, Talip Çeter, Münevver Pinar, Ferda Öner Erkekol, Sevim Bavbek, Faruk Özer
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 43(6)
Sensitization to Alternaria and Cladosporium has been reported to be 3% to 30% in European countries. However, in Turkey, there is limited data about the prevalence of sensitization to these molds and the intensity of the two mold spores in Ankara at
Publikováno v:
Allergy. 66:1256-1257
Publikováno v:
Allergy. 56(6)
Background: Although the role of inhaled fungi in inducing asthma has been repeatedly confirmed, there are few reports about the association of asthma with dermatophyte sensitivity and the causal role of Trichophyton allergy in asthma. The objective